| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PAS | 8.08e-05 | 25 | 175 | 4 | PF00989 | |
| Domain | PAS_fold | 8.08e-05 | 25 | 175 | 4 | IPR013767 | |
| Domain | Unchr_dom_Cys-rich | 2.16e-04 | 13 | 175 | 3 | IPR014853 | |
| Domain | C8 | 2.16e-04 | 13 | 175 | 3 | SM00832 | |
| Domain | PAS | 2.18e-04 | 32 | 175 | 4 | SM00091 | |
| Domain | WTX | 2.60e-04 | 3 | 175 | 2 | PF09422 | |
| Domain | DUF3454 | 2.60e-04 | 3 | 175 | 2 | PF11936 | |
| Domain | DUF3454_notch | 2.60e-04 | 3 | 175 | 2 | IPR024600 | |
| Domain | Uncharacterised_FAM123 | 2.60e-04 | 3 | 175 | 2 | IPR019003 | |
| Domain | DUF3454 | 2.60e-04 | 3 | 175 | 2 | SM01334 | |
| Domain | TIL_dom | 2.73e-04 | 14 | 175 | 3 | IPR002919 | |
| Domain | NPIP | 2.73e-04 | 14 | 175 | 3 | IPR009443 | |
| Domain | PAS | 2.77e-04 | 34 | 175 | 4 | PS50112 | |
| Domain | PAS | 2.77e-04 | 34 | 175 | 4 | IPR000014 | |
| Domain | VWFC_1 | 3.47e-04 | 36 | 175 | 4 | PS01208 | |
| Domain | VWF_type-D | 4.14e-04 | 16 | 175 | 3 | IPR001846 | |
| Domain | VWFD | 4.14e-04 | 16 | 175 | 3 | PS51233 | |
| Domain | VWD | 4.14e-04 | 16 | 175 | 3 | SM00216 | |
| Domain | VWD | 4.14e-04 | 16 | 175 | 3 | PF00094 | |
| Domain | VWFC_2 | 4.29e-04 | 38 | 175 | 4 | PS50184 | |
| Domain | VWC | 4.29e-04 | 38 | 175 | 4 | SM00214 | |
| Domain | Notch | 5.17e-04 | 4 | 175 | 2 | IPR008297 | |
| Domain | NODP | 5.17e-04 | 4 | 175 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 5.17e-04 | 4 | 175 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 5.17e-04 | 4 | 175 | 2 | IPR010660 | |
| Domain | NOD | 5.17e-04 | 4 | 175 | 2 | PF06816 | |
| Domain | NOD | 5.17e-04 | 4 | 175 | 2 | SM01338 | |
| Domain | NODP | 5.17e-04 | 4 | 175 | 2 | SM01339 | |
| Domain | VWF_dom | 6.31e-04 | 42 | 175 | 4 | IPR001007 | |
| Domain | VWC_out | 7.02e-04 | 19 | 175 | 3 | SM00215 | |
| Domain | RII_binding_1 | 8.57e-04 | 5 | 175 | 2 | PF10522 | |
| Domain | LNR | 8.57e-04 | 5 | 175 | 2 | PS50258 | |
| Domain | RII_binding_1 | 8.57e-04 | 5 | 175 | 2 | IPR018459 | |
| Domain | PH | TBC1D2 ARHGEF18 ARHGEF11 PLEKHM1 AFAP1L2 PLCH2 AKAP13 ARHGEF26 PSD4 | 1.27e-03 | 278 | 175 | 9 | SM00233 |
| Domain | PH_DOMAIN | TBC1D2 ARHGEF18 ARHGEF11 PLEKHM1 AFAP1L2 PLCH2 AKAP13 ARHGEF26 PSD4 | 1.30e-03 | 279 | 175 | 9 | PS50003 |
| Domain | PH_domain | TBC1D2 ARHGEF18 ARHGEF11 PLEKHM1 AFAP1L2 PLCH2 AKAP13 ARHGEF26 PSD4 | 1.33e-03 | 280 | 175 | 9 | IPR001849 |
| Domain | DM_2 | 1.78e-03 | 7 | 175 | 2 | PS50809 | |
| Domain | DM | 1.78e-03 | 7 | 175 | 2 | SM00301 | |
| Domain | - | 1.78e-03 | 7 | 175 | 2 | 4.10.1040.10 | |
| Domain | Notch_dom | 1.78e-03 | 7 | 175 | 2 | IPR000800 | |
| Domain | DM_DNA-bd | 1.78e-03 | 7 | 175 | 2 | IPR001275 | |
| Domain | DM | 1.78e-03 | 7 | 175 | 2 | PF00751 | |
| Domain | DM_1 | 1.78e-03 | 7 | 175 | 2 | PS40000 | |
| Domain | Notch | 1.78e-03 | 7 | 175 | 2 | PF00066 | |
| Domain | NL | 1.78e-03 | 7 | 175 | 2 | SM00004 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 GBF1 ZNF628 NLRX1 CUL9 CARD10 ICE1 PPARA ARHGEF11 FAAP100 BIRC6 ELAC2 PLEKHM1 PCNX2 PIKFYVE MROH6 ZNF341 SETD5 ZNF408 SURF6 MCM3AP SCN5A KBTBD11 ANKRD11 AKAP13 POLL LRBA NOTCH1 | 6.14e-12 | 1105 | 183 | 28 | 35748872 |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 18483410 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.92e-07 | 168 | 183 | 9 | 30631154 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TBC1D2 RNF213 ICE1 AMER3 ZNF831 BIRC6 SSPOP AFAP1L2 MROH8 TBC1D4 ZNF408 MCM3AP RECQL4 AKAP13 CHD6 PLXNB3 CXCR2 | 4.13e-07 | 736 | 183 | 17 | 29676528 |
| Pubmed | Deficiency of Notch signaling in pericytes results in arteriovenous malformations. | 1.42e-06 | 5 | 183 | 3 | 33148887 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.40e-06 | 184 | 183 | 8 | 32908313 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXM1 ZBTB38 BHLHA9 GON4L PPARA ATF6B CRX SOX7 HOXB2 USF3 DMRT3 DMRT2 FOXI2 DLX4 LBX2 ZNF541 NPAS1 | 6.94e-06 | 908 | 183 | 17 | 19274049 |
| Pubmed | NCOA2 PDGFRB NPIPB12 TMEM54 DBNDD2 PKD1L1 GON4L FAM91A1 TACC2 KANK2 FAAP100 AFAP1L2 SURF6 RECQL4 TENM1 KDM4A ADAM17 GNAS MARCKS NOTCH1 | 7.08e-06 | 1215 | 183 | 20 | 15146197 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | AMER1 ZCCHC8 MAP3K8 OTUD1 FAM91A1 SNX16 TTC1 SOWAHC KANK2 PASK RIC8B MROH6 MCM3AP RNF10 SMN1 GNAS CDC27 CRTC2 | 1.04e-05 | 1038 | 183 | 18 | 26673895 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 CACNA1C AMER1 ARHGEF18 RNF213 PPARA SSPOP PLEKHM1 LRP8 PCNX2 RIC8B USF3 TBC1D4 SETD5 ANKRD11 PPP1R9B AKAP13 CHD6 GNAS LRBA ARHGEF26 NOTCH3 | 1.31e-05 | 1489 | 183 | 22 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 CAAP1 GBF1 ZCCHC8 TBC1D2 FAM91A1 ZNF217 ZNF318 DBN1 USP19 PASK RBM25 TBC1D4 MDC1 KLHDC4 | 1.65e-05 | 774 | 183 | 15 | 15302935 |
| Pubmed | 2.04e-05 | 105 | 183 | 6 | 9628581 | ||
| Pubmed | AMER1 GBF1 ZCCHC8 DBN1 TTC1 BIRC6 TBC1D4 PPP1R9B MAP3K21 NOTCH1 CRTC2 | 2.70e-05 | 446 | 183 | 11 | 24255178 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16192272 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 21191019 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22183976 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22337624 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 28486700 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20551051 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17608096 | ||
| Pubmed | Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. | 2.75e-05 | 2 | 183 | 2 | 9620803 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 12897186 | ||
| Pubmed | Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis. | 2.75e-05 | 2 | 183 | 2 | 21768299 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25700162 | ||
| Pubmed | Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. | 2.75e-05 | 2 | 183 | 2 | 18069660 | |
| Pubmed | Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature. | 2.75e-05 | 2 | 183 | 2 | 34878922 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18167350 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31566039 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17881497 | ||
| Pubmed | ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma. | 2.75e-05 | 2 | 183 | 2 | 29180185 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 29023469 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24728738 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25744398 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 12626544 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 14595837 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16507912 | ||
| Pubmed | Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine. | 2.75e-05 | 2 | 183 | 2 | 20635912 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 36769246 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19913791 | ||
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 2.75e-05 | 2 | 183 | 2 | 25341504 | |
| Pubmed | Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis. | 2.75e-05 | 2 | 183 | 2 | 33021719 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10882063 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 29776401 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32155316 | ||
| Pubmed | The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC). | 2.75e-05 | 2 | 183 | 2 | 29301506 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26634853 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 33905845 | ||
| Pubmed | Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells. | 2.75e-05 | 2 | 183 | 2 | 34831323 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26563570 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26744411 | ||
| Pubmed | Notch signaling differentially regulates Atoh7 and Neurog2 in the distal mouse retina. | 5.00e-05 | 14 | 183 | 3 | 25100656 | |
| Pubmed | TSPOAP1 GON4L CUL9 FAM91A1 USP19 SETD5 MCM3AP CHD6 RAB11FIP4 PLXNB3 | 6.48e-05 | 407 | 183 | 10 | 12693553 | |
| Pubmed | GBF1 NTNG1 ARHGEF18 RNF213 TOGARAM1 BIRC6 PIKFYVE AHRR USF3 PRMT7 MEX3B | 6.64e-05 | 493 | 183 | 11 | 15368895 | |
| Pubmed | 6.79e-05 | 130 | 183 | 6 | 12421765 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 15987768 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 8.23e-05 | 3 | 183 | 2 | 25846406 | |
| Pubmed | Deficiency in SNM1 abolishes an early mitotic checkpoint induced by spindle stress. | 8.23e-05 | 3 | 183 | 2 | 15542852 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 27697639 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 20801121 | ||
| Pubmed | Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. | 8.23e-05 | 3 | 183 | 2 | 28552773 | |
| Pubmed | Ric-8B is a GTP-dependent G protein alphas guanine nucleotide exchange factor. | 8.23e-05 | 3 | 183 | 2 | 21467038 | |
| Pubmed | FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma. | 8.23e-05 | 3 | 183 | 2 | 29700308 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 21132303 | ||
| Pubmed | Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. | 8.23e-05 | 3 | 183 | 2 | 19704010 | |
| Pubmed | The WTX/AMER1 gene family: evolution, signature and function. | 8.23e-05 | 3 | 183 | 2 | 20843316 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7615640 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7918097 | ||
| Pubmed | Smooth muscle Notch1 mediates neointimal formation after vascular injury. | 8.23e-05 | 3 | 183 | 2 | 19433762 | |
| Pubmed | KCTD10 regulates brown adipose tissue thermogenesis and metabolic function via Notch signaling. | 8.23e-05 | 3 | 183 | 2 | 34854382 | |
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 8.23e-05 | 3 | 183 | 2 | 29767458 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7698746 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22898814 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 8.23e-05 | 3 | 183 | 2 | 11948212 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 27840976 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 33664344 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 17223797 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 18573889 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 8645602 | ||
| Pubmed | Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. | 8.23e-05 | 3 | 183 | 2 | 31346528 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 17510296 | ||
| Pubmed | PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. | 8.23e-05 | 3 | 183 | 2 | 34846251 | |
| Pubmed | GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome. | 8.23e-05 | 3 | 183 | 2 | 23389772 | |
| Pubmed | Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development. | 8.23e-05 | 3 | 183 | 2 | 23818617 | |
| Pubmed | Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17). | 8.23e-05 | 3 | 183 | 2 | 25412626 | |
| Pubmed | Expression patterns of the Wtx/Amer gene family during mouse embryonic development. | 8.23e-05 | 3 | 183 | 2 | 20503382 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 20529858 | ||
| Pubmed | SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα. | 8.23e-05 | 3 | 183 | 2 | 31851938 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 35011564 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 31330219 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22170052 | ||
| Pubmed | Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure. | 8.23e-05 | 3 | 183 | 2 | 21859973 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 33673337 | ||
| Pubmed | Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice. | 8.23e-05 | 3 | 183 | 2 | 28062509 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 8.23e-05 | 3 | 183 | 2 | 21471519 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22942284 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 12652642 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | GBF1 TSPOAP1 ARHGEF18 USF3 PLCH2 MDC1 AKAP13 MEX3B NOTCH1 CRTC2 | 1.02e-04 | 430 | 183 | 10 | 35044719 |
| Pubmed | FOXM1 NCOA2 TACC2 ZNF217 ZNF318 BIRC6 PIKFYVE SOX7 AHRR RNF10 KDM4A DLX4 LBX2 | 1.06e-04 | 709 | 183 | 13 | 22988430 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.35e-04 | 361 | 183 | 9 | 26167880 | |
| Pubmed | 1.39e-04 | 212 | 183 | 7 | 19521566 | ||
| Interaction | TOP3B interactions | RIN3 GBF1 ZNF628 NLRX1 CUL9 CARD10 ICE1 PPARA ARHGEF11 KANK2 FAAP100 BIRC6 ELAC2 PLEKHM1 PCNX2 PIKFYVE MROH6 ZNF341 SETD5 ZNF408 SURF6 MCM3AP MDC1 SCN5A KBTBD11 ANKRD11 PPP1R9B AKAP13 POLL KDM4A GNAS LRBA MEX3B NOTCH1 | 1.25e-07 | 1470 | 175 | 34 | int:TOP3B |
| Cytoband | 16p11.2 | 1.29e-04 | 191 | 184 | 6 | 16p11.2 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | RIN3 TMEM54 NLRX1 BHLHA9 KCP CUL9 GFRA3 ACTL7B PCNX2 SOX7 ESYT3 AFAP1L2 FOXI2 LBX2 SLC7A10 | 7.07e-06 | 544 | 183 | 15 | M1936 |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP | 1.17e-05 | 199 | 183 | 9 | M8294 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN | 1.21e-05 | 200 | 183 | 9 | M3579 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | RIN3 TMEM54 NLRX1 BHLHA9 KCP CUL9 GFRA3 ACTL7B PCNX2 SOX7 ESYT3 AFAP1L2 FOXI2 LBX2 SLC7A10 | 1.33e-05 | 574 | 183 | 15 | MM820 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | RIN3 PDE1B BHLHA9 CARD10 ZNF217 PPARA STIL SOX7 ESYT3 AFAP1L2 DMRT2 HMCN1 KCNC3 SCN5A KCNK6 GNAS MAP3K21 ARHGEF26 SLC7A10 NOTCH1 TPBG | 2.12e-05 | 1074 | 183 | 21 | M1941 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | PAG1 NPIPB4 RNF213 NPIPB5 AKAP12 LRP8 RBM25 TENM1 ANKRD11 LRBA IL2RA | 6.70e-10 | 197 | 184 | 11 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Treg|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ZBTB38 CUL9 RNF213 ZNF831 HOXB2 TBC1D4 LAT TNFRSF8 IL2RA SLC7A10 | 7.96e-09 | 192 | 184 | 10 | b7e08cadb50f66c2efdde45e0fa8bab29367269b |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.14e-08 | 185 | 184 | 9 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-07 | 193 | 184 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-07 | 155 | 184 | 8 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.11e-07 | 172 | 184 | 8 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-07 | 174 | 184 | 8 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-06 | 186 | 184 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 187 | 184 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.19e-06 | 188 | 184 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-06 | 190 | 184 | 8 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-06 | 190 | 184 | 8 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.35e-06 | 191 | 184 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.40e-06 | 192 | 184 | 8 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.51e-06 | 194 | 184 | 8 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.76e-06 | 198 | 184 | 8 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-06 | 199 | 184 | 8 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-06 | 199 | 184 | 8 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.21e-06 | 151 | 184 | 7 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 156 | 184 | 7 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 156 | 184 | 7 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 156 | 184 | 7 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.31e-06 | 163 | 184 | 7 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.31e-06 | 163 | 184 | 7 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 6.23e-06 | 167 | 184 | 7 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 173 | 184 | 7 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 174 | 184 | 7 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 174 | 184 | 7 | 9eab43885496b8586f8ec5b4bcb1fd5b209218e5 | |
| ToppCell | Healthy_donor-Treg|Healthy_donor / disease group, cell group and cell class (v2) | 8.14e-06 | 174 | 184 | 7 | 1d76921c8404b5be5fbe9f3157d53578033f2ad2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.77e-06 | 176 | 184 | 7 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 176 | 184 | 7 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 177 | 184 | 7 | 5d70fe2b0592362d664b3b4c84eb450ec2335957 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 177 | 184 | 7 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 177 | 184 | 7 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 177 | 184 | 7 | 48bcf603ec9593eedd81f3831cf9fde89fad368f | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 9.80e-06 | 179 | 184 | 7 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.02e-05 | 180 | 184 | 7 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 181 | 184 | 7 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-05 | 182 | 184 | 7 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 183 | 184 | 7 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-05 | 184 | 184 | 7 | 300edc4aa3ce55f309005c02c315fa0102ea9da7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 184 | 184 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 184 | 184 | 7 | 8b397f9c18ed7abecdbcbd586d0ddadf07cf6e75 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-05 | 184 | 184 | 7 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 122 | 184 | 6 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.21e-05 | 185 | 184 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Treg|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 185 | 184 | 7 | c1a44b7eed72a673923a7c44d06f891f18aa5aad | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 186 | 184 | 7 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.26e-05 | 186 | 184 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.26e-05 | 186 | 184 | 7 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 186 | 184 | 7 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 186 | 184 | 7 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 186 | 184 | 7 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.29e-05 | 124 | 184 | 6 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 187 | 184 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 188 | 184 | 7 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-05 | 189 | 184 | 7 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 189 | 184 | 7 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.39e-05 | 189 | 184 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-05 | 190 | 184 | 7 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 190 | 184 | 7 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 190 | 184 | 7 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 191 | 184 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Treg|normal_Lymph_Node / Location, Cell class and cell subclass | 1.54e-05 | 192 | 184 | 7 | d2c2a98d331522a3ab7973bfaf4396ef4d684888 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 194 | 184 | 7 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 184 | 7 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 195 | 184 | 7 | 7b181e5b05becec3fd5031849affa9a135b26d3f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 195 | 184 | 7 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 195 | 184 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.76e-05 | 196 | 184 | 7 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 196 | 184 | 7 | c16fbd23d9e117831b55ab3da5b08b22dd972432 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 197 | 184 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-05 | 197 | 184 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 198 | 184 | 7 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-Treg|Control / Disease, condition lineage and cell class | 1.94e-05 | 199 | 184 | 7 | 6b7eb14bf03aa05f2d4ac4f5dd1ccf41a7e47bd1 | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 1.94e-05 | 199 | 184 | 7 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 199 | 184 | 7 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 199 | 184 | 7 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 199 | 184 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 1.94e-05 | 199 | 184 | 7 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 199 | 184 | 7 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-05 | 200 | 184 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 200 | 184 | 7 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 200 | 184 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 200 | 184 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.01e-05 | 200 | 184 | 7 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.01e-05 | 200 | 184 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| Disease | Schizophrenia | CACNA1C PAG1 ABCA1 PDGFRB NTNG1 PPARA DBN1 ARHGEF11 GFRA3 LRP8 HP PPP1R9B GNAS TNFRSF1A IL2RA SLC7A10 NPAS1 | 2.03e-05 | 883 | 174 | 17 | C0036341 |
| Disease | infantile myofibromatosis (is_implicated_in) | 3.46e-05 | 2 | 174 | 2 | DOID:0080109 (is_implicated_in) | |
| Disease | Myofibromatosis | 3.46e-05 | 2 | 174 | 2 | C0206648 | |
| Disease | Infantile myofibromatosis | 3.46e-05 | 2 | 174 | 2 | cv:C0432284 | |
| Disease | Myofibromatosis | 3.46e-05 | 2 | 174 | 2 | cv:C0206648 | |
| Disease | Infantile myofibromatosis | 3.46e-05 | 2 | 174 | 2 | C0432284 | |
| Disease | Hypertensive disease | 1.41e-04 | 190 | 174 | 7 | C0020538 | |
| Disease | neutrophil percentage of leukocytes | RIN3 ZBTB38 TSPOAP1 SH2D3C ARHGEF18 ZNF831 CSF3R AKAP13 TNFRSF1A IL2RA SLC7A10 CXCR2 | 2.87e-04 | 610 | 174 | 12 | EFO_0007990 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.08e-04 | 99 | 174 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | alkaline phosphatase measurement | NCOA2 RIN3 ADAMTSL1 KCP NTNG1 ZNF318 PPARA PLEKHM1 SURF6 RP1L1 RECQL4 RNF10 AKAP13 LRBA MAP4K2 NOTCH1 | 3.55e-04 | 1015 | 174 | 16 | EFO_0004533 |
| Disease | Allergic Reaction | 5.31e-04 | 63 | 174 | 4 | C1527304 | |
| Disease | Eczema | 5.33e-04 | 310 | 174 | 8 | HP_0000964 | |
| Disease | Hypersensitivity | 5.63e-04 | 64 | 174 | 4 | C0020517 | |
| Disease | Malignant neoplasm of breast | FOXM1 NCOA2 RPS6KB2 TACC2 ZNF318 DBN1 AKAP12 CRX HP OTOGL TENM1 LRBA CDC27 NOTCH1 NOTCH3 ZNF541 | 6.53e-04 | 1074 | 174 | 16 | C0006142 |
| Disease | cancer antigen 15.3 measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0010585 | |
| Disease | Precocious Puberty | 7.12e-04 | 7 | 174 | 2 | C0034013 | |
| Disease | Cryptogenic sexual precocity | 7.12e-04 | 7 | 174 | 2 | C0271527 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Central Precocious Puberty | 7.12e-04 | 7 | 174 | 2 | C0342543 | |
| Disease | visceral:subcutaneous adipose tissue ratio | 7.91e-04 | 70 | 174 | 4 | EFO_0004767 | |
| Disease | intestinal cancer (implicated_via_orthology) | 8.81e-04 | 32 | 174 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Brugada syndrome | 9.46e-04 | 8 | 174 | 2 | cv:C1142166 | |
| Disease | mannose measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0006958 | |
| Disease | Testotoxicosis | 9.46e-04 | 8 | 174 | 2 | C1504412 | |
| Disease | helix rolling | 9.46e-04 | 8 | 174 | 2 | EFO_0007670 | |
| Disease | cortical surface area measurement | NCOA2 COL5A2 NPR2 RIN3 ADAMTSL1 SGCA CUL9 ELAC2 PLEKHM1 LRP8 PIGQ LRRIQ1 DMRT3 DMRT2 RP1L1 MDC1 PPP1R9B RAB11FIP4 | 1.04e-03 | 1345 | 174 | 18 | EFO_0010736 |
| Disease | response to 4'-epidoxorubicin, response to antineoplastic agent | 1.21e-03 | 9 | 174 | 2 | GO_0097327, GO_1902522 | |
| Disease | response to sulfasalazine, Drug-induced agranulocytosis | 1.35e-03 | 37 | 174 | 3 | EFO_0008324, HP_0012235 | |
| Disease | monocyte percentage of leukocytes | PAG1 PDGFRB TSPOAP1 SH2D3C ARHGEF11 CSF3R MCM3AP AKAP13 GPAT2 SLC7A10 MARCKS CXCR2 | 1.39e-03 | 731 | 174 | 12 | EFO_0007989 |
| Disease | Anemia, Sickle Cell | 1.51e-03 | 10 | 174 | 2 | C0002895 | |
| Disease | Reactive hypoglycemia | 1.51e-03 | 10 | 174 | 2 | C0271710 | |
| Disease | Fasting Hypoglycemia | 1.51e-03 | 10 | 174 | 2 | C0271708 | |
| Disease | temporomandibular joint disorder | 1.51e-03 | 10 | 174 | 2 | EFO_0005279 | |
| Disease | blood urea nitrogen measurement | 1.52e-03 | 452 | 174 | 9 | EFO_0004741 | |
| Disease | Calcium channel blocker use measurement | 1.71e-03 | 213 | 174 | 6 | EFO_0009930 | |
| Disease | Eczema, allergic rhinitis | 1.79e-03 | 215 | 174 | 6 | EFO_0005854, HP_0000964 | |
| Disease | Hypoglycemia | 1.84e-03 | 11 | 174 | 2 | C0020615 | |
| Disease | attention function measurement | 1.89e-03 | 148 | 174 | 5 | EFO_0007636 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 1.91e-03 | 295 | 174 | 7 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | lymphocyte percentage of leukocytes | RIN3 ZBTB38 GBF1 TSPOAP1 ARHGEF18 ZNF831 CSF3R TNFRSF1A IL2RA SLC7A10 CXCR2 | 2.06e-03 | 665 | 174 | 11 | EFO_0007993 |
| Disease | Tinnitus, wellbeing measurement | 2.55e-03 | 96 | 174 | 4 | EFO_0007869, HP_0000360 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.64e-03 | 97 | 174 | 4 | DOID:3083 (is_marker_for) | |
| Disease | cystatin C measurement | 2.76e-03 | 402 | 174 | 8 | EFO_0004617 | |
| Disease | multiple sclerosis | NCOA2 ADAMTSL1 ZBTB38 TSPOAP1 KCP AKAP13 TNFRSF1A IL2RA SLC7A10 MARCKS | 2.88e-03 | 594 | 174 | 10 | MONDO_0005301 |
| Disease | Impaired cognition | 3.00e-03 | 14 | 174 | 2 | C0338656 | |
| Disease | suntan | 3.28e-03 | 103 | 174 | 4 | EFO_0004279 | |
| Disease | Retinitis Pigmentosa | 3.40e-03 | 104 | 174 | 4 | C0035334 | |
| Disease | hair colour measurement | RIN3 ZBTB38 SNX16 ZNF831 AKAP12 ZNF750 ANKRD11 AKAP13 ARHGEF26 KLHDC4 | 3.68e-03 | 615 | 174 | 10 | EFO_0007822 |
| Disease | neutrophil measurement | 4.08e-03 | 177 | 174 | 5 | EFO_0803548 | |
| Disease | leukemia | 4.22e-03 | 55 | 174 | 3 | C0023418 | |
| Disease | 1-Methylhistidine measurement | 4.44e-03 | 17 | 174 | 2 | EFO_0021543 | |
| Disease | idiopathic pulmonary fibrosis | 4.67e-03 | 57 | 174 | 3 | EFO_0000768 | |
| Disease | Tachycardia | 4.97e-03 | 18 | 174 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 4.97e-03 | 18 | 174 | 2 | C0080203 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 4.97e-03 | 18 | 174 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | body surface area | ZBTB38 PPARA GFRA3 SETD5 ANKRD11 AKAP13 GNAS ARHGEF26 TPBG PSD4 | 5.01e-03 | 643 | 174 | 10 | EFO_0022196 |
| Disease | granulocyte percentage of myeloid white cells | 5.28e-03 | 268 | 174 | 6 | EFO_0007997 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 5.53e-03 | 19 | 174 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | ovulation | 5.53e-03 | 19 | 174 | 2 | GO_0030728 | |
| Disease | birth weight, parental genotype effect measurement | 5.73e-03 | 192 | 174 | 5 | EFO_0004344, EFO_0005939 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCEPIGSPEDAQDLP | 196 | Q6UXB8 | |
| ACLEPTDGLPQSEPP | 621 | A9YTQ3 | |
| EGPLGPSPDDDLCVS | 431 | Q8N944 | |
| DLPCPPDPASDTKDV | 626 | A0FGR9 | |
| PAGDSPDQLLLEPCA | 811 | Q9BWT7 | |
| ESCPDEEEGPFSLPE | 786 | Q6ZSZ5 | |
| LLCPGDSPAVAAAPE | 361 | Q9Y614 | |
| SLPEAPLDVAPEPAC | 2071 | Q6UB99 | |
| LPCPEGLDPDTDDAP | 4811 | Q9NR09 | |
| EEEENGPCPPSLLPA | 501 | Q9NS82 | |
| SLEGSPPPCLGQEEA | 1391 | Q02952 | |
| AEDSAEDLGGPCPEP | 16 | Q7RTU4 | |
| LELEEAPEPSCRCPG | 41 | P0DPF5 | |
| PLEPTQDGSAIETCP | 461 | Q7Z2Z2 | |
| GNPIPDTPCQAGEEE | 1421 | O95477 | |
| EPEDCAPVVVELPEG | 366 | Q9Y312 | |
| DPSSAPETDGQFLPC | 306 | Q12802 | |
| LSLVGCEVVPDPSPD | 396 | Q8N4X5 | |
| ELGPCPEDGSDAPLE | 1496 | O15085 | |
| GPTVPLSCAPVEESD | 201 | C9JDP6 | |
| PDDSLENSPPGDDCL | 511 | Q5JTC6 | |
| NAPAPCTPEEDLTGL | 151 | Q96DR7 | |
| APPSDNPPCAFDLDD | 431 | P20594 | |
| IPACPEEEPLLDNST | 261 | Q8IYA2 | |
| IEGPCNEEAAAPEAP | 266 | Q9H8G2 | |
| PLCGPAEHPQELEAD | 81 | Q92988 | |
| TSLEGDCEPSPAPAV | 221 | Q9UGP5 | |
| DPLPLPAGNCTDEEG | 246 | Q9HC84 | |
| PECVLTPLPPSADDN | 286 | Q92617 | |
| ECVLTPLPPSADDNL | 306 | Q92617 | |
| ESPCGIIIPHENSPD | 641 | P49756 | |
| DPPAPCSQEEAGAAV | 1146 | O95153 | |
| PCAPEIPDCVEQGSE | 101 | Q86YS3 | |
| CEEASSPGPEPTEPE | 426 | Q99742 | |
| PECVLTPLPPSADDN | 286 | F8W0I5 | |
| LPSGCPEAEEPANLE | 131 | Q8N6L0 | |
| LPPPCPASFNADEDD | 271 | Q9Y257 | |
| DPHLGTPSPEDCELE | 291 | Q12851 | |
| PEPETGECQPAAAAE | 46 | Q5VV17 | |
| LDAGPEDTCPSAEEP | 851 | Q96RG2 | |
| AFSPCLPPDLGSVDV | 771 | Q9Y5H6 | |
| AGRDIPPPLIEEACE | 1436 | P46531 | |
| QESPDACLPPTVPEA | 1031 | Q14676 | |
| TDIADDGCPKPPEIA | 26 | P00738 | |
| TPVSLPPEPACEDAD | 136 | O43561 | |
| PISDDSCIAVPPLEG | 226 | Q658Y4 | |
| EECGVEPDAPLSSLP | 1016 | O60318 | |
| EAPALEPPSAACLDL | 216 | Q6ZQN5 | |
| DLPIDECEGPKPASQ | 561 | Q8N6G6 | |
| QAPPLEDIADDCSPG | 346 | P41279 | |
| ADIPASPCGEPEEEV | 266 | Q96I76 | |
| HLSEPCEPPDATEQG | 2081 | A6NKB5 | |
| LCPAPSIDAVEPLTG | 831 | Q9ULL4 | |
| TDSKEPPGELCPDVL | 36 | Q9BUK6 | |
| DELSPCEEEAPPSPA | 511 | Q01064 | |
| ACLPAELTFGPADAP | 106 | Q6ZS72 | |
| PFLLDAAPCEPESLE | 31 | P25025 | |
| RCEAPAAAPEVSEEP | 1371 | Q9UM47 | |
| ESELPPRAGNEEECP | 356 | O75164 | |
| DGVTVDPALLPPACL | 1691 | P50851 | |
| PECVLTPLPPSADDN | 286 | A8MRT5 | |
| ECVLTPLPPSADDNL | 306 | A8MRT5 | |
| EPCSLNSALEPAPEG | 81 | A6NGR9 | |
| GCATLLNFDELPEPP | 526 | Q16643 | |
| LNFDELPEPPATFCD | 531 | Q16643 | |
| TGLCSDPEEPQEPAA | 256 | Q86UT6 | |
| CAGTALSDDPEGPPV | 36 | Q9GZP1 | |
| VPAEPPEACGELSNG | 66 | Q9BSG0 | |
| ESGPGPTSPLCALEE | 36 | Q6XYB7 | |
| TDLDIPDIPGLHCEP | 46 | Q9H579 | |
| PECVLTPLPPSADDN | 286 | C9JG80 | |
| ECVLTPLPPSADDNL | 306 | C9JG80 | |
| EGELPPDLTENTCPS | 86 | Q9P1G2 | |
| DPFLDECPSDVLPEQ | 621 | Q0VG06 | |
| SCAREGEPDSPDIPE | 1251 | Q96JM4 | |
| ITLSCEADGLPPPDI | 4096 | Q96RW7 | |
| EPACPGALEDICDPA | 211 | P14652 | |
| PECLLTPLPPSADDN | 286 | E5RHQ5 | |
| EEPEDLDCGRPEPSA | 31 | Q5K4E3 | |
| DIPPESLPCDDSSLL | 916 | Q9Y2I7 | |
| GFEPEPSDPCVEERL | 441 | Q9UFP1 | |
| EPQCCLEDPAGSPLE | 21 | Q9NZH6 | |
| EDLPEPVEPSALCSD | 1361 | Q9Y2F5 | |
| DVPAEDDPSPCALET | 306 | Q13936 | |
| ELEEDVCGAPRSTPP | 21 | Q9Y5R5 | |
| PSEEPSVPADCLEAA | 76 | O60609 | |
| VEPATPEEGEPATQC | 36 | A1L429 | |
| VEPATPEEGEPATQC | 36 | A6NDE8 | |
| PECTLSTGLLEPADP | 621 | Q9NVM4 | |
| GDENCAEPSAPLPAE | 2681 | Q8TD26 | |
| IDLGDPDAADVFLPC | 166 | Q9BQY9 | |
| EDPRISIPDDGCPFV | 431 | Q9NQL9 | |
| LSDPCALLPDPAVEE | 671 | Q53ET0 | |
| PDAPCDIDHASAPLG | 336 | Q6NUI2 | |
| EHSPGPPLADAECQE | 1266 | Q3T8J9 | |
| IPACPEEEPLLDNST | 311 | Q3MJ40 | |
| SASDAEHCPELPPVD | 16 | P20851 | |
| CQDVLDCADPVTPPG | 76 | P05997 | |
| VTPAPSQEDDCVFGP | 801 | Q99062 | |
| EAQPECSPEAPPAEA | 316 | P29966 | |
| AELCDDDPPEIPHAT | 21 | P01589 | |
| DLVPASLPCEELAEP | 121 | Q8TF61 | |
| SLPCEELAEPGLVPA | 126 | Q8TF61 | |
| LSQAPDPPTLSGAEC | 121 | Q6UWN5 | |
| LPPCVDEPELLFSEG | 551 | Q08050 | |
| PPEIPSELGACDFEK | 1756 | Q92538 | |
| SELCLDLPDPPEDPV | 246 | Q63ZY3 | |
| EDSLEEAGSPAPGPC | 416 | Q8TBB5 | |
| GCPRDIPTNSPELEE | 266 | P01042 | |
| PVCVSPLGCDDDLPS | 2071 | Q8IWT3 | |
| DSPPRSETECPDGLL | 146 | Q6PJP8 | |
| IPACPEEEPLLDNST | 311 | A2RUR9 | |
| PFESLCEIGEKPDPD | 151 | P30260 | |
| EDSIPTCSPEVGGPE | 2401 | Q8TDX9 | |
| RPSTDVCPDPLGISD | 126 | O43186 | |
| PAGPCFQDEPEEVRL | 196 | P54317 | |
| CLGETREPEDPAPAL | 906 | Q14114 | |
| GSIIPIEPDCDEEPT | 1896 | Q3ZCN5 | |
| EPEPELEQLPDSGCP | 1081 | P09619 | |
| PECVLTPLPPSADDN | 286 | A6NJU9 | |
| EDCSSALPTDQPPLG | 241 | Q8TB24 | |
| SPLCPLSPLEAGDLE | 6 | Q07869 | |
| GEASVPSPDGCPELQ | 346 | Q6ZN04 | |
| ECDASTPELAHPPEL | 91 | Q9Y2I2 | |
| EPPEAPQGCLSPSDL | 646 | Q9Y4G2 | |
| PEGLECPALDAELSD | 11 | Q9BT81 | |
| CPALDAELSDGQSPP | 16 | Q9BT81 | |
| PTPLCSGPEAEEEPC | 3231 | A2VEC9 | |
| SCPSLPAGPTGVEED | 1386 | A2VDJ0 | |
| EGEGEPELSPADACP | 16 | Q9UBS0 | |
| PGSCEEPKLSPDGLE | 641 | Q5TCX8 | |
| GPPLSPQETDCAIEA | 216 | Q9NVN3 | |
| CPRPASEEDTDAVGP | 416 | O94761 | |
| ASGETLPDPLDPTCS | 851 | Q6ZWJ8 | |
| NEPIPVENDGEACGP | 56 | Q5JWF2 | |
| LAVGVEGPCQDEPPS | 696 | Q9BRB3 | |
| LGPAPSAAPCVDEAL | 356 | Q8NDX1 | |
| AEPQAPGCGETPEDS | 1121 | Q14524 | |
| PSPVEERCGDSPNSE | 71 | Q9C0A6 | |
| ESTPEISERPAGECP | 581 | Q2M3M2 | |
| GPECDVPEEQCIDPT | 586 | Q9UKZ4 | |
| PPPICPDSLDDADAL | 246 | Q16637 | |
| GPSEDLELPPHGCEE | 171 | Q53LP3 | |
| VEATPEGACTEPREP | 181 | O75683 | |
| LGNSCDPEEEAPPPV | 246 | Q9NWQ8 | |
| ASPEELASPEERACP | 86 | O94819 | |
| LASPEERACPEEPAA | 91 | O94819 | |
| LAGLPPSEELADPCS | 141 | Q96KW2 | |
| CPPTEAPDRDFLVDA | 276 | Q16586 | |
| EPDPAACDLGDERPK | 6 | Q96N87 | |
| PPPGNAEDDTVCLDL | 556 | P78536 | |
| TESLAPPLCLLGDDP | 126 | Q99941 | |
| PPLCLLGDDPTSSFE | 131 | Q99941 | |
| CDPPGPADLVLEEGD | 166 | O43916 | |
| ALVGPDDVEFCSPPA | 11 | O75829 | |
| APEPEPCEASELPAK | 246 | Q9ULV3 | |
| DDLLCPHPAAESPSD | 1061 | Q15596 | |
| AEEPEPEAEPGSCLA | 531 | Q2L4Q9 | |
| HPLLEDGCIEDDPAP | 2861 | Q63HN8 | |
| PTGPGEEAPDACAVD | 611 | Q32MQ0 | |
| PDDGPCLLSVPDQCV | 36 | Q8TCV5 | |
| DPGREVPECLEITPT | 101 | Q15468 | |
| ACEDPHDLLATPTPE | 101 | O94966 | |
| PPAIQPLDDEDVFLC | 41 | Q9BYN7 | |
| SSPCPNELDLPVPEG | 556 | Q6NZY4 | |
| GEDCESPAPEADRPH | 6 | Q9HA47 | |
| SELLALAPDCPFDPT | 136 | Q969K7 | |
| ILAEELCTPPDPGAA | 291 | Q9BQ52 | |
| DLPVCEPSGESAAPD | 31 | Q13064 | |
| SASAEPCPAEGTEEP | 1436 | Q8IWN7 | |
| ALDCLPEDGELLPSP | 391 | P41226 | |
| PEDGELLPSPEDCAL | 396 | P41226 | |
| CSLETIAEEPAPGPG | 1001 | O75038 | |
| SEPEPEGLPEACDDL | 456 | Q8N5U6 | |
| ASPGEDAAEPCIDPG | 206 | Q9H9D4 | |
| DAAEPCIDPGSQSPS | 211 | Q9H9D4 | |
| DTTFEAPPLGTQPDC | 321 | P28908 | |
| PEQETEPPLGSCSDV | 561 | P28908 | |
| SAEPPCNDGLLESFP | 831 | Q68DE3 | |
| GEAPPCQPDSVALLD | 1041 | O95359 | |
| EVVVPGSPGDCLPEE | 256 | O60343 | |
| ACEEAAPAGVLPELP | 291 | Q8TBC5 | |
| QPGTCSPDLAAPLDE | 416 | O75362 | |
| TLLECDSAPPEGPEP | 751 | Q8N5H7 | |
| ELNSADLDCDPILPP | 336 | Q13641 | |
| PEPSGDSPLGLCQSE | 881 | Q8NAP3 | |
| EASGFPEDPLPCAVT | 326 | Q9Y4F4 | |
| PSPGEADSILEDPSC | 996 | Q5JPB2 | |
| LCLDDPPGPFDSLEE | 211 | P57768 | |
| TDTQEAECAGPPVPD | 21 | Q99614 | |
| DIEEALCGPAALPPA | 436 | P19438 | |
| PIGCNSSDPADFEPI | 2051 | Q5VUA4 | |
| QVPPPEEESGDCARS | 26 | Q9BYX2 | |
| LKEAPPEEEACGDSP | 226 | Q9H0D2 | |
| APAALDTELPEEPCL | 326 | Q9H0D2 | |
| SEELLLEHQPCPGPD | 306 | Q5EBL2 | |
| DDCRPGTPPSDLIEI | 31 | Q8NCA9 | |
| APGEPCPLAQEEVIE | 641 | Q14003 | |
| CVEIPGLSEEEDPAP | 431 | Q96SB3 |